UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2008.

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             .

Commission File Number 333-133319

LIFECARE HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware	51-0372090
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification Number)

5560 Tennyson Parkway Plano, Texas	75024
(Address of Principal Executive Offices)	(Zip Code)

(469) 241-2100

(Registrant’s telephone number, including area code)

None

(Former name, former address and former fiscal year, if changes since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. Please see definition of “accelerated and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer:  ¨    Accelerated Filer:  ¨    Non-Accelerated Filer:  x    Smaller Reporting Company:  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

As of November 1, 2008, the registrant had 100 shares of Common Stock, par value $0.01 per share, outstanding.

LIFECARE HOLDINGS, INC.

TABLE OF CONTENTS

PART I	FINANCIAL INFORMATION
ITEM 1.	CONSOLIDATED FINANCIAL STATEMENTS	3
	CONDENSED CONSOLIDATED BALANCE SHEETS	3
	CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS	4
	CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER’S EQUITY	5
	CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS	6
	NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	7
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	19
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	29
ITEM 4.	CONTROLS AND PROCEDURES	29
PART II	OTHER INFORMATION	29
ITEM 1.	LEGAL PROCEEDINGS	29
ITEM 1A.	RISK FACTORS	30
ITEM 6.	EXHIBITS	30
SIGNATURES		31

2

PART 1: FINANCIAL INFORMATION

ITEM 1: CONSOLIDATED FINANCIAL STATEMENTS

LIFECARE HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

September 30, 2008 and December 31, 2007

(In thousands, except share data)

(unaudited)

	September 30, 2008			December 31, 2007
Assets
Current assets:
Cash and cash equivalents	$	22,253		$	17,816
Accounts receivable, net of allowance for doubtful accounts of $18,948 and $19,394 respectively		66,992			66,911
Income taxes		1,511			2,025
Other current assets		8,959			13,597
Total current assets		99,715			100,349
Property and equipment, net		86,055			83,317
Other assets		13,420			15,675
Identifiable intangibles, net		17,590			18,445
Goodwill		263,970			263,970
	$	480,750		$	481,756
Liabilities and Stockholder’s Equity (Deficit)
Current liabilities:
Current installments of long-term debt	$	2,550		$	2,550
Current installments of obligations under capital leases		1,227			1,604
Current installment of lease financing obligation		410			—
Estimated third party payor settlements		2,589			5,744
Accounts payable		22,518			23,438
Accrued payroll		10,608			6,351
Accrued vacation		4,126			3,489
Accrued insurance		1,241			1,087
Accrued interest		1,935			5,181
Accrued other		4,216			2,739
Total current liabilities		51,420			52,183
Long-term debt, excluding current installments		401,800			393,713
Obligations under capital leases, excluding current installments		2,173			741
Lease financing obligation, excluding current installments		18,527			16,590
Accrued insurance		5,030			4,714
Other noncurrent liabilities		14,332			13,582
Total liabilities		493,282			481,523
Commitments and contingencies
Stockholder’s equity (deficit):
Common stock, $0.01 par value, 100 shares authorized, issued and outstanding		—			—
Additional paid-in capital		171,880			171,677
Accumulated deficit		(184,412	)		(171,444	)
Total stockholder’s equity (deficit)		(12,532	)		233
	$	480,750		$	481,756

See accompanying notes to condensed consolidated financial statements.

3

LIFECARE HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(In thousands)

(Unaudited)

	Three Months Ended September 30, 2008			Three Months Ended September 30, 2007			Nine Months Ended September 30, 2008			Nine Months Ended September 30, 2007
Net patient service revenue	$	82,394		$	77,553		$	257,786		$	242,475
Salaries, wages, and benefits		40,520			40,389			123,411			117,604
Supplies		8,353			8,191			26,209			24,951
Rent		6,331			5,712			19,060			15,691
Other operating expenses		19,902			21,180			61,475			63,286
Provision for doubtful accounts		151			1,404			2,600			4,287
Depreciation and amortization		3,018			2,952			8,605			8,685
Goodwill impairment charge		—			3,834			—			3,834
Interest expense, net		9,209			8,967			28,135			26,466
Total expenses		87,484			92,629			269,495			264,804
Operating loss		(5,090	)		(15,076	)		(11,709	)		(22,329	)
Equity in loss of joint venture		—			(106	)		—			(448	)
Loss before income taxes		(5,090	)		(15,182	)		(11,709	)		(22,777	)
Provision (benefit) for income taxes		835			(1,953	)		1,259			(2,652	)
Net loss	$	(5,925	)	$	(13,229	)	$	(12,968	)	$	(20,125	)

See accompanying notes to condensed consolidated financial statements.

4

LIFECARE HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholder’s Equity (Deficit)

For the nine months ended September 30, 2008

(In thousands)

(Unaudited)

	Common Stock		Additional Paid-in Capital		Accumulated Deficit			Total Stockholder’s Equity (Deficit)
Balance, December 31, 2007	$	—	$	171,677	$	(171,444	)	$	233
Equity compensation amortization		—		203		—			203
Net loss		—		—		(12,968	)		(12,968	)
Balance, September 30, 2008	$	—	$	171,880	$	(184,412	)	$	(12,532	)

See accompanying notes to condensed consolidated financial statements.

5

LIFECARE HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	Nine Months Ended September 30, 2008			Nine Months Ended September 30, 2007
Cash flows from operating activities:
Net loss	$	(12,968	)	$	(20,125	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		10,202			9,865
Provision for doubtful accounts		2,600			4,287
Impairment charges		—			3,834
Equity in losses of joint venture		—			448
Deferred income taxes		—			2,087
Equity compensation amortization		203			519
Changes in operating assets and liabilities:
Accounts receivable		(2,681	)		(7,409	)
Current income taxes		514			(2,169	)
Prepaid expenses and other current assets		(213	)		(954	)
Other assets		656			(131	)
Estimated third-party payor settlements		(3,155	)		(7,884	)
Accounts payable and accrued expenses		4,605			3,322
Other liabilities		1,068			1,509
Net cash provided by (used in) operating activities		831			(12,801	)
Cash from investing activities:
Purchases of property and equipment		(11,722	)		(37,252	)
Sale-leaseback proceeds		3,714			26,669
Net cash used in investing activities		(8,008	)		(10,583	)
Cash flows from financing activities:
Deferred financing cost		—			(1,089	)
Proceeds from lease financing obligation		3,829			10,466
Payment on lease financing obligation		(200	)		—
Net change in borrowings under the line of credit		10,000			—
Payments of notes payable and long-term debt		(1,913	)		(2,550	)
Proceeds from capital lease financing		1,802			—
Payments on obligations under capital leases		(1,904	)		(3,122	)
Net cash provided by financing activities		11,614			3,705
Net increase (decrease) in cash and cash equivalents		4,437			(19,679	)
Cash and cash equivalents, beginning of period		17,816			33,250
Cash and cash equivalents, end of period	$	22,253		$	13,571
Supplemental disclosure of cash flow information:
Cash:
Interest paid	$	31,844		$	29,751
Net income taxes paid (received)		746			(2,570	)
Noncash:
Equipment purchased through capital lease financing		1,157			298
Removal of lease financing obligation for facility sale-leaseback		—			32,759
Accrual of purchases of property and equipment		—			3,898
Accrual of reimbursement due from REIT		—			7,676

See accompanying notes to condensed consolidated financial statements.

6

LifeCare Holdings, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

(1) Basis of Presentation

LifeCare Holdings, Inc. (the “Company”) is a wholly owned subsidiary of LCI Holdco, LLC (“Holdco”). Holdco is a wholly owned subsidiary of LCI Holding Company, Inc. (“Holdings”), which is owned by an investor group that includes affiliates of The Carlyle Group and members of the board of directors. The investor group acquired Holdings pursuant to a merger that occurred on August 11, 2005 (the “Merger”).

The accompanying unaudited condensed consolidated financial statements and financial information have been prepared in accordance with generally accepted accounting principles, and reflect all adjustments that are, in the opinion of management, necessary for a fair presentation of the results of the interim periods. The accompanying financial statements for the three and nine month periods ended September 30, 2008 and 2007 are not necessarily indicative of annualized financial results.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto for the year ended December 31, 2007 included in the Form 10-K we filed on March 28, 2008 with the Securities and Exchange Commission. Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted as permitted by the rules and regulations of the Securities and Exchange Commission, although we believe the disclosure is adequate to make the information presented not misleading.

(2) Summary of Significant Accounting Policies

Use of Estimates

The preparation of the financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from those estimates.

Goodwill

We review our goodwill annually, or more frequently if circumstances warrant a more timely review, to determine if there has been an impairment. Per the guidance of Financial Accounting Standards Board Emerging Issues Task Force (“EITF”) Topic No. D-101 Clarification of Reporting Unit Guidance in Paragraph 30 of FASB Statement No. 142, (“EITF Topic No. D-101”), we review goodwill based upon one reporting unit, as the Company is managed as one operating segment in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 131, Disclosures about Segments of an Enterprise and Related Information, (“SFAS 131”). In calculating the fair value of the reporting unit, we use various assumptions including projected cash flows and discount rates. If projected future cash flows decline from the current amounts projected by management, additional impairments may be recorded.

Income Taxes

For the nine months ended September 30, 2008, income tax expense recorded represents the estimated income tax liability for certain state income taxes and revised estimates to the beginning of the year valuation allowance based on the final filing of amended tax returns and carryback of the 2007 net operating loss. We expect that no benefit or expense will be realized during 2008 for current year federal income taxes based on recent taxable loss trends and a projected taxable loss for the remainder of 2008. We anticipate that federal net operating losses generated during 2008 will be offset by an increase in the valuation allowance against net deferred tax assets.

Financial Accounting Standards Board (“FASB”) Interpretation No. 48, Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109 (“FIN 48”) prescribes a threshold of more-likely-than-not for recognition of tax benefits of uncertain tax positions taken or expected to be taken in a tax return. We record accrued interest and penalties associated with uncertain tax positions, if any, as income tax expense in the condensed consolidated statement of operations.

The federal statute of limitations remains open for original tax returns filed for 2005 through 2007. State jurisdictions generally have statutes of limitations ranging from three to five years. The state income tax impact of federal income tax changes remains subject to examination by various states for a period up to one year after formal notification to the states.

7

Stock Compensation

We account for equity-based compensation in accordance with SFAS No. 123(R), Share-Based Payment, (“SFAS 123(R)”). Pursuant to SFAS 123(R), we estimate the fair value of awards on the date of grant, or the date of award modification if applicable, using the Black-Scholes option pricing model. The weighted average fair value of options granted during the nine months ended September 30, 2008 was $0 per share and was calculated based on the following assumptions: expected volatility of 40%, expected dividend yield of 0%, expected life of 6.25 years, and a risk-free interest rate of 3.00% to 3.39%. Expected volatility was derived using data drawn from other public healthcare companies for five to seven years prior to the date of grant and award modification. The expected life was computed utilizing the simplified method as permitted by the Securities and Exchange Commission’s Staff Accounting Bulletin No. 110, Share-Based Payment. The expected forfeiture rates are 50% and are based upon a review of our recent history and expectations. The risk-free interest rate is based on the approximate yield on seven-year United States Treasury Bonds as of the date of grant and award modification. There were 1,728,000 options granted during the nine months ended September 30, 2008 (see note 5).

Recent Accounting Pronouncements

In September 2006, the FASB issued SFAS No. 157, Fair Value Measurement (“SFAS 157”) which defines fair value, establishes a framework for the measurement of fair value, and enhances disclosures about fair value measurements. SFAS 157 does not require any new fair value measures, but is effective for fair value measures already required or permitted by other standards for fiscal years beginning after November 15, 2007. We adopted SFAS 157 on January 1, 2008. SFAS 157 is required to be applied prospectively, except for certain financial instruments. The adoption of Statement 157 had no impact on our financial position, results of operations or liquidity.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities, including an Amendment to SFAS No. 115 (“SFAS 159”). SFAS 159 allows the measurement of many financial instruments and certain other assets and liabilities at fair value on an instrument-by-instrument basis under a fair value option. SFAS 159 became effective for fiscal years that begin after November 15, 2007. The adoption of SFAS 159 had no impact on our financial position, results of operations or liquidity.

Reclassifications

Certain reclassifications have been made to the consolidated financial statements for prior periods to conform to the presentation of the 2008 consolidated financial statements.

(3) Net Patient Service Revenue and Allowance for Doubtful Accounts

We recognize in the consolidated financial statements the impact of adjustments, if any, to Medicare reimbursement when the amounts can be reasonably determined. Net revenues for the three months ended September 30, 2008 and 2007 included decreases of $0.1 million and $0.4 million, respectively, related to changes in estimates and settlements on prior year cost reports filed with the Medicare program. For the nine months ended September 30, 2008 and 2007, decreases of $1.6 million and $0.8 million, respectively, were included in net revenues related to changes in estimates and settlements on prior year cost reports filed with the Medicare program. In addition, the provision for doubtful accounts for the nine-months ended September 30, 2008 of $2.6 million reflects the benefits of improved collections during 2008 on aged accounts previously reserved for and favorable accounts receivable aging trends.

(4) Long-Term Debt

Long-term debt consists of the following (in thousands):

	September 30, 2008			December 31, 2007
Senior secured credit facility—term loan	$	247,350		$	249,263
9  1/4% senior subordinated notes		147,000			147,000
Revolving credit facility		10,000			—
Total long-term debt		404,350			396,263
Current installments of long-term debt		(2,550	)		(2,550	)
Long-term debt, excluding current installments	$	401,800		$	393,713

The senior secured credit facility consists of (i) a $60.0 million Revolving Credit Facility, subject to availability, of which $10.0 million is outstanding, and (ii) a $247.4 million Term Loan B Facility. Availability of borrowings under our Revolving Credit Facility are generally dependent upon our ability to meet the maximum leverage ratio test included in the senior secured credit facility.

8

The senior secured credit facility requires us to comply on a quarterly basis with certain financial covenants, including an interest coverage ratio test and a maximum leverage ratio test. These financial covenants become more restrictive on a periodic basis throughout the remaining term of the senior secured credit facility beginning with the fiscal period ending December 31, 2008. In addition, the senior secured credit facility includes various negative covenants, including limitations on indebtedness, liens, investments, permitted businesses and transactions and other matters, as well as certain customary representations and warranties, affirmative covenants and events of default including payment defaults, breach of representations and warranties, covenant defaults, cross defaults to certain indebtedness, certain events of bankruptcy, certain events under ERISA, material judgments, actual or asserted failure of any guaranty or security document supporting the senior secured credit facility to be in full force and effect, change of control, and certain subjective provisions. We believe we are currently in compliance with the covenants of our senior secured credit facility as amended.

We may not be able to continue to satisfy the covenant requirements in subsequent periods. If we are unable to maintain compliance with the covenants contained in our senior secured credit facility, an event of default would occur. During the continuation of an event of default, the lenders under the senior secured credit facility are entitled to take various actions, including accelerating amounts due under the senior secured credit facility, terminating our access to our revolving credit facility and all other actions generally available to a secured creditor. An uncured event of default would have a material adverse effect on our financial position, results of operations and cash flow. In the event a financial covenant is not met, our senior secured credit facility provides for certain limited cure rights which provide us the ability to issue permitted cure securities in exchange for cash or otherwise receive cash that would be contributed to our capital in an amount that is necessary to satisfy the financial covenant required on a pro forma basis. The cure right amount, if exercised, continues to be considered a component of consolidated EBITDA, as defined in the senior secured credit agreement, on a trailing 4 quarter basis.

(5) Stock Options

Successor Stock Option Plan

At September 30, 2008, there were 2.9 million shares of common stock of Holdings available under the 2005 Equity Incentive Plan (“Plan”) for stock option grants and other incentive awards, including restricted stock units. Options granted generally have an exercise price equal to the estimated fair value of the shares on the date of grant and expire 10 years from the date of grant. A restricted stock unit is a contractual right to receive one share of Holdings’ common stock in the future. Options typically vest one-quarter on each of the first four anniversary dates of the grant and restricted stock units vest one-quarter upon grant and one-quarter each year thereafter.

Losses for the three months ended September 30, 2008 and 2007 and the nine months ended September 30, 2008 and 2007 include $0.1 million, $0.2 million, $0.2 million, and $0.5 million respectively, of pre-tax compensation costs related to stock-based compensation arrangements.

The following table summarizes stock option activity during the nine months ended September 30, 2008:

	Number of Shares		Weighted average exercise price
Balance at December 31, 2007	841,000		$	2.50
Granted	1,728,000			2.50
Exercised	—			—
Forfeited	(118,500	)		2.50
Expired	(70,000	)		2.50
Balance at September 30, 2008	2,380,500		$	2.50

At September 30, 2008, the weighted average remaining contractual life of outstanding options was 9.0 years, and 261,250 stock options were exercisable. At September 30, 2008, the vested stock options had a weighted average exercise price of $2.50, remaining weighted average contractual life of 7.6 years and no intrinsic value.

As of September 30, 2008, there was approximately $0.7 million of total unrecognized compensation costs related to stock options. These costs are expected to be recognized over a period of approximately two years.

9

Restricted Stock Awards

The following table summarizes restricted stock award activity during the nine months ended September 30, 2008:

	Number of Shares		Weighted Average Grant Date Fair Value
Number of unvested shares:
Outstanding at December 31, 2007	10,000		$	5.05
Vested	(10,000	)		5.05
Outstanding at September 30, 2008	—		$

One of the holders of restricted stock resigned from the Company during 2008. As part of the separation agreement, the 10,000 outstanding unvested shares were vested. Additionally, 20,000 shares were purchased from the holder for $2.50 per share.

In 2008, we entered into a restricted stock award agreement with our chief executive officer and president whereby they would be awarded 400,000 and 300,000 shares, respectively, if we meet or exceed certain financial goals for the year ended December 31, 2008. The grant-date per share fair value of these awards was $0.

As of September 30, 2008, there was no unrecognized compensation costs related to restricted stock awards.

(6) Regulatory Matters

All healthcare providers are required to comply with a significant number of laws and regulations at the federal and state government levels. These laws are complex, and in many instances, providers do not have the benefit of significant regulatory or judicial interpretation as to how to interpret and/or apply these laws and regulations. The U.S. Department of Justice and other federal agencies are increasing resources dedicated to regulatory investigations and compliance audits of healthcare providers. As a healthcare provider, we are subject to these regulatory efforts. Healthcare providers that do not comply with these laws and regulations may be subject to civil or criminal penalties, the loss of their licenses, or restriction in their ability to participate in various federal and state healthcare programs. We endeavor to conduct our business in compliance with applicable laws and regulations, including healthcare fraud and abuse laws.

We undertake various procedures to assure that our annual cost reports are correctly prepared and filed in accordance with applicable Medicare regulations governing provider reimbursement. During 2004 and 2003, we conducted an internal review of our previously filed cost reports. As a result of this review, which covered the years 1997 through 2001, we made certain adjustments in 2003 to our previously reported allowable home office expenses. The findings of this review and proposed amendments to the home office cost reports were submitted to the Office of Inspector General of the Department of Health and Human Services (“OIG”), which reviewed our findings. On June 12, 2006, we entered into a Settlement Agreement and a Certification of Compliance Agreement (“CCA”) with the OIG that settled these matters. The amount paid in connection with this settlement was approximately $2.6 million, which was funded out of a specific escrow account established as part of the Merger that occurred on August 11, 2005. The CCA is effective for three years. It requires, among other things, that we (1) continue to maintain our corporate compliance program, (2) submit an annual report to OIG regarding certain specified items, including our ongoing corporate compliance audit findings in areas such as cost reporting, physician contracting and charge master reviews, and (3) report the occurrence of certain other events.

(7) Commitments and Contingencies

At the time of Hurricane Katrina, we operated an 82-bed facility in New Orleans located in Memorial Medical Center. In the aftermath of the hurricane, an investigation was conducted by the Louisiana Attorney General’s office. The investigation culminated in a Grand Jury being convened in February of 2007 to determine if criminal charges should be filed against three individuals, who were not our employees, but who were caring for patients in Memorial Medical Center after the hurricane. Two of the individuals were subsequently granted immunity and the Grand Jury declined to indict the third. Neither the Company nor its employees have been named in any lawsuits or matters related to illegal or criminal activities associated with Hurricane Katrina.

We are currently defending ourselves against a variety of Hurricane Katrina related lawsuits or matters under review by the Louisiana Patient Compensation Fund. We are vigorously defending ourselves in these lawsuits, however, we cannot predict the ultimate resolution of these matters. We maintained $15.0 million of general and professional liability insurance during this period, subject to a $1.0 million per claim retention. We believe that under our insurance policies, only one retention is applicable to the Hurricane Katrina matters since these matters all arose from a single

10

event, process or condition. Our insurance carriers are currently paying all costs related to these claims, but have sent reservation of rights letters which challenge, among other things, the application of one retention to the Hurricane Katrina related matters. To the extent it is ultimately determined that a separate retention applies to each of these claims, we could experience significant losses related to these Hurricane Katrina matters which would negatively impact our financial position, liquidity and results of operations.

Significant reductions in the patient service revenues earned by a hospital may occur if we are unable to maintain the certification of the hospital as a long-term acute care (“LTAC”) hospital in accordance with Medicare regulations. Additionally, many of our hospitals operate in space leased from general acute care hospitals (“host hospitals”); consequently, these “hospitals within a hospital” (“HIH”) are subject to additional specific Medicare HIH regulations in addition to the general LTAC hospital regulations. The HIH regulations are designed to ensure that the hospitals are organizationally and functionally independent of their host hospitals. If an LTAC hospital located in a host hospital fails to meet the HIH regulations, it may also lose its status as an LTAC hospital. The determinations are made on an annual basis.

A provider that loses its ability to receive Medicare payments pursuant to the Long-Term Acute Care Prospective Payment System (“PPS”) must go through the same certification process as new LTAC hospital providers must go through to obtain their initial certification to be reimbursed pursuant to PPS. During this re-certification period, which could range from six to nine months, the provider would be paid for providing services to Medicare beneficiaries at rates that are lower than rates currently paid pursuant to PPS.

In 2007, one of our hospitals, with multiple campus locations, failed to achieve the twenty-five day length of stay requirement for the twelve months ended December 31, 2007. The LTAC hospital regulations provide that a hospital may correct this type of deficiency in the subsequent cost report period following the period in which the twenty-five day length of stay requirement was not achieved. The fiscal intermediary for this hospital reviewed the hospital’s discharge information for the five months ending May 31, 2008 for compliance with the twenty-five day length of stay requirement. Based upon this review, the fiscal intermediary determined that the hospital met the twenty-five day length of stay requirement and issued its recommendation to CMS that the hospital continue to be certified as an LTAC hospital. The hospital is currently eligible and will continue to be eligible to receive Medicare payments pursuant to LTAC hospital regulations for discharges on or after January 1, 2009. We believe that this hospital, and our remaining hospitals, are currently in compliance with the Medicare regulations regarding LTAC hospitals and will maintain compliance under these regulations.

During December 2006, we entered into an agreement to form a new joint venture with an unrelated party in the New Orleans market that will own and operate LTAC hospitals. During 2007, we contributed to the joint venture our hospital licenses, Medicare provider numbers and certain remaining equipment from our former New Orleans operations in exchange for a 49.99% ownership in the joint venture. In connection with this joint venture, we guaranteed, via the issuance of a letter of credit, $0.8 million of a $1.5 million line of credit established by the new joint venture. The joint venture’s line of credit is secured by certain assets, including accounts receivable and moveable equipment of the joint venture, along with our letter of credit. Pursuant to FASB Interpretation No. 45, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, we have established a carrying value of $0.4 million associated with this guarantee, which is recorded in other noncurrent liabilities. This value was determined based upon our estimates and probabilities of the likelihood that the operations of this joint venture would result in us becoming liable under the established letter of credit.

We have certain other pending and threatened litigation and claims incurred in the ordinary course of business. We believe (based, in part, on the advice of legal counsel) that the probable resolution of such contingencies will not exceed our insurance coverage and will not materially affect the consolidated financial position, results of operations or liquidity of the Company.

(8) Sale-Leaseback and Lease Financing Obligations

On September 1, 2006, a newly formed subsidiary (“Tenant”) of the Company entered into a separate Master Lease Agreement (“Lease”) with Health Care REIT, Inc. (“Landlord”) to acquire and develop hospital facilities (“Facilities”). The Company granted Landlord the limited right and option, for a three-year period, to acquire or develop and subsequently lease Facilities to Tenant. Tenant will sublease each Facility to a wholly-owned subsidiary of Tenant (“Subtenant”) and the licensed operator of each Facility will be the Tenant or a Subtenant. In connection with this Lease, the Landlord has agreed to make available up to $250.0 million for investments in hospital facilities, subject to approval of the Landlord and certain terms and conditions. The initial term of the Lease is 15 years and the Tenant has one 15-year renewal option. Upon each addition of a Facility, the term will be extended to a date 15 years from the date of the addition. At the end of the term, the Tenant may exercise an option to purchase the Facilities at a price equal to the greater of the investment amount (which includes acquisition costs, development costs, renovation costs, closing cost and fees) or fair value.

11

The initial rent for each Facility under the Lease is computed based on a predetermined spread over the rate of a 15-year U.S. Treasury Note and is subject to an annual inflation adjustment. Lease payments is secured by receivables, assignment of leases and rents, assignment of management agreements, subordination of management fees and distributions, and cross-default, as well as a second lien on personal property and equipment owned by the Tenant. The Lease contains customary covenants, representations and warranties.

Our Boise, Idaho facility was the first facility to be developed under this Lease. This facility was completed in March 2008 with construction cost of approximately $19.6 million. Through September 30, 2008, the Landlord had made payments to us of approximately $18.9 million as reimbursement for these capital expenditures. This particular facility under this Lease is accounted for as a lease financing obligation whereby the asset remains capitalized on our balance sheet. This facility opened during April 2008.

In connection with this facility and in accordance with the terms of the Lease, we have issued $6.1 million in letters of credit through September 30, 2008, payable to the Landlord utilizing capacity available for letters of credit under our revolving credit agreement.

The Tenant and any future subsidiaries established under Tenant, will not be guarantors of the Senior Secured Credit Facility or the 9  ¹/4% Senior Subordinated Notes.

(9) Financial Information for Subsidiary Guarantors and Non-guarantor Subsidiaries under the Senior Subordinated Notes

The senior subordinated notes are fully and unconditionally guaranteed by substantially all of our wholly-owned subsidiaries (the “Subsidiary Guarantors”), however, certain of our subsidiaries did not guarantee the senior subordinated notes (the Non-Guarantor Subsidiaries”).

Presented below is condensed consolidating financial information for LifeCare Holdings, Inc., the Subsidiary Guarantors, and the Non-Guarantor Subsidiaries for the three and nine months ended at September 30, 2008 and 2007. The equity method has been used with respect to investments in subsidiaries. Separate financial statements of the Subsidiary Guarantors are not presented.

12

LifeCare Holdings, Inc.

Condensed Consolidating Balance Sheet

September 30, 2008

(in thousands)

	Parent			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminations			Consolidated Totals
Assets
Current assets:
Cash and cash equivalents	$	—		$	22,252		$	1		$	—		$	22,253
Accounts receivable, net of allowance for doubtful accounts		—			66,601			391			—			66,992
Due to/from related parties		146,381			(137,664	)		(8,717	)		—			—
Income taxes		1,784			(273	)		—			—			1,511
Other current assets		—			8,573			386			—			8,959
Total current assets		148,165			(40,511	)		(7,939	)		—			99,715
Investment in subsidiary		241,538			—			—			(241,538	)		—
Property and equipment, net		—			63,259			22,796			—			86,055
Other assets		9,880			3,540			—			—			13,420
Identifiable intangibles, net		—			17,590			—			—			17,590
Goodwill		—			263,970			—			—			263,970
	$	399,583		$	307,848		$	14,857		$	(241,538	)	$	480,750
Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Current installments of long-term debt	$	2,550		$	—		$	—			—		$	2,550
Current installments of obligations under capital leases		—			976			251			—			1,227
Current installment of lease financing obligation		—			—			410			—			410
Estimated third-party payor settlements		—			2,589			—			—			2,589
Accounts payable		330			22,168			20			—			22,518
Accrued payroll		—			10,575			33			—			10,608
Accrued vacation		—			4,030			96			—			4,126
Accrued insurance		—			1,241			—			—			1,241
Accrued interest		1,935			—			—			—			1,935
Accrued other		—			3,945			271			—			4,216
Total current liabilities		4,815			45,524			1,081			—			51,420
Long-term debt, excluding current installments		401,800			—			—			—			401,800
Obligations under capital leases, excluding current installments		—			1,732			441			—			2,173
Lease-financing obligation, excluding current installments		—			—			18,527			—			18,527
Accrued insurance		—			5,030			—			—			5,030
Other noncurrent liabilities		5,500			8,832			—			—			14,332
Total liabilities		412,115			61,118			20,049			—			493,282
Commitments and contingencies
Stockholders’ equity (deficit):
Common stock		—			—			—			—			—
Additional paid-in capital		171,880			60			—			(60	)		171,880
Retained earnings (deficit)		(184,412	)		246,670			(5,192	)		(241,478	)		(184,412	)
Total stockholders’ equity (deficit)		(12,532	)		246,730			(5,192	)		(241,538	)		(12,532	)
	$	399,583		$	307,848		$	14,857		$	(241,538	)	$	480,750

13

LifeCare Holdings, Inc.

Condensed Consolidating Statement of Operations

For the Three Months Ended September 30, 2008

(in thousands)

	Parent			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminations			Consolidated Totals
Net patient service revenue	$	—		$	82,039		$	355		$	—		$	82,394
Salaries, wages and benefits		62			39,528			930			—			40,520
Supplies		—			8,256			97			—			8,353
Rent		—			6,239			92			—			6,331
Other operating expenses		303			19,160			439			—			19,902
Provision for doubtful accounts		—			144			7			—			151
Depreciation and amortization		—			2,524			494			—			3,018
Intercompany (income) expenses		696			(723	)		27			—			—
Interest expense, net		8,747			14			448			—			9,209
Total expenses		9,808			75,142			2,534			—			87,484
Operating income (loss)		(9,808	)		6,897			(2,179	)		—			(5,090	)
Earnings in investments in subsidiaries		4,647			—			—			(4,647	)		—
Income (loss) before income taxes		(5,161	)		6,897			(2,179	)		(4,647	)		(5,090	)
Provision for income taxes		764			71			—			—			835
Net income (loss)	$	(5,925	)	$	6,826		$	(2,179	)	$	(4,647	)	$	(5,925	)

LifeCare Holdings, Inc.

Condensed Consolidating Statement of Operations

For the Nine Months Ended September 30, 2008

(in thousands)

	Parent			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminations			Consolidated Totals
Net patient service revenue	$	—		$	257,393		$	393		$	—		$	257,786
Salaries, wages and benefits		215			120,938			2,258			—			123,411
Supplies		—			26,057			152			—			26,209
Rent		—			18,692			368			—			19,060
Other operating expenses		834			59,537			1,104			—			61,475
Provision for doubtful accounts		—			2,592			8			—			2,600
Depreciation and amortization		—			7,928			677			—			8,605
Intercompany (income) expenses		4,051			(4,078	)		27			—			—
Interest expense, net		27,009			242			884			—			28,135
Total expenses		32,109			231,908			5,478			—			269,495
Operating income (loss)		(32,109	)		25,485			(5,085	)		—			(11,709	)
Earnings in investments in subsidiaries		19,904			—			—			(19,904	)		—
Income (loss) before income taxes		(12,205	)		25,485			(5,085	)		(19,904	)		(11,709	)
Provision for income taxes		763			496			—			—			1,259
Net income (loss)	$	(12,968	)	$	24,989		$	(5,085	)	$	(19,904	)	$	(12,968	)

14

LifeCare Holdings, Inc.

Condensed Consolidating Statement of Cash Flows

For the Nine Months Ended September 30, 2008

(in thousands)

	Parent			Guarantor			Nonguarantor			Eliminations			Consolidated
Cash flows from operating activities:
Net income (loss)	$	(12,968	)	$	24,989		$	(5,085	)	$	(19,904	)	$	(12,968	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		1,597			7,928			677			—			10,202
Provision for doubtful accounts		—			2,592			8			—			2,600
Equity compensation amortization		203			—			—			—			203
Changes in operating assets and liabilities:
Accounts receivable		—			(2,282	)		(399	)		—			(2,681	)
Current income taxes		610			(96	)		—			—			514
Prepaid expenses and other current assets		301			(322	)		(192	)		—			(213	)
Change in investments in subsidiary		(19,904	)		—			—			19,904			—
Other assets		(81	)		737			—			—			656
Due to from related parties		25,205			(32,973	)		7,768			—			—
Estimated third-party payor settlements		—			(3,155	)		—			—			(3,155	)
Accounts payable and accrued expenses		(3,050	)		8,361			(706	)		—			4,605
Other liabilities		—			1,068			—			—			1,068
Net cash provided by (used in) operating activities		(8,087	)		6,847			2,071			—			831
Cash from investing activities:
Purchases of property and equipment		—			(6,170	)		(5,552	)		—			(11,722	)
Sale-leaseback proceeds		—			3,714			—			—			3,714
Net cash used in investing activities		—			(2,456	)		(5,552	)		—			(8,008	)
Cash flows from financing activities:
Proceeds from lease financing obligation		—			—			3,829			—			3,829
Payment on lease financing obligation		—			—			(200	)		—			(200	)
Net change in borrowings under the line of credit		10,000			—			—			—			10,000
Payments of notes payable and long-term debt		(1,913	)		—			—			—			(1,913	)
Proceeds from capital lease financing		—			1,802			—			—			1,802
Payments on obligations under capital leases		—			(1,757	)		(147	)		—			(1,904	)
Net cash provided by financing activities		8,087			45			3,482			—			11,614
Net increase in cash and cash equivalents		—			4,436			1			—			4,437
Cash and cash equivalents, beginning of period		—			17,816			—			—			17,816
Cash and cash equivalents, end of period	$	—		$	22,252		$	1		$	—		$	22,253

15

LifeCare Holdings, Inc.

Condensed Consolidating Balance Sheet

December 31, 2007

(in thousands)

	Parent			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminations			Consolidated Totals
Assets
Current assets:
Cash and cash equivalents	$	—		$	17,816		$	—		$	—		$	17,816
Accounts receivable, net of allowance for doubtful accounts		—			66,911			—			—			66,911
Due to/from related parties		171,285			(170,336	)		(949	)		—			—
Income taxes		2,548			(523	)		—			—			2,025
Other current assets		301			11,819			1,477			—			13,597
Total current assets		174,134			(74,313	)		528			—			100,349
Investment in subsidiary		221,638			—			—			(221,638	)		—
Property and equipment, net		—			66,235			17,082			—			83,317
Other assets		11,398			4,277			—			—			15,675
Identifiable intangibles, net		—			18,445			—			—			18,445
Goodwill		—			263,970			—			—			263,970
	$	407,170		$	278,614		$	17,610		$	(221,638	)	$	481,756
Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Current installments of long-term debt	$	2,550		$	—		$	—		$	—		$	2,550
Current installments of obligations under capital leases		—			1,604			—			—			1,604
Estimated third-party payor settlements		—			5,744			—			—			5,744
Accounts payable		(7	)		22,317			1,128			—			23,438
Accrued payroll		—			6,351			—			—			6,351
Accrued vacation		—			3,489			—			—			3,489
Accrued insurance		—			1,087			—			—			1,087
Accrued interest		5,181			—			—			—			5,181
Accrued other		—			2,739			—			—			2,739
Total current liabilities		7,724			43,331			1,128			—			52,183
Long-term debt, excluding current installments		393,713			—			—			—			393,713
Obligations under capital leases, excluding current installments		—			741			—			—			741
Lease-financing obligation, excluding current installments		—			—			16,590			—			16,590
Accrued insurance		—			4,714			—			—			4,714
Other noncurrent liabilities		5,500			8,082			—			—			13,582
Total liabilities		406,937			56,868			17,718			—			481,523
Stockholders’ equity (deficit):
Common stock		—			—			—			—			—
Additional paid-in capital		171,677			62			—			(62	)		171,677
Retained earnings (deficit)		(171,444	)		221,684			(108	)		(221,576	)		(171,444	)
Total stockholders’ equity (deficit)		233			221,746			(108	)		(221,638	)		233
	$	407,170		$	278,614		$	17,610		$	(221,638	)	$	481,756

16

LifeCare Holdings, Inc.

Condensed Consolidating Statement of Operations

For the Three Months Ended September 30, 2007

(in thousands)

	Parent			Guarantor Subsidiaries			Nonguarantor Subsidiaries		Eliminations		Consolidated Totals
Net patient service revenue	$	—		$	77,553		$	—	$	—	$	77,553
Salaries, wages and benefits		194			40,195			—		—		40,389
Supplies		—			8,191			—		—		8,191
Rent		—			5,712			—		—		5,712
Other operating expenses		210			20,970			—		—		21,180
Provision for doubtful accounts		—			1,404			—		—		1,404
Depreciation and amortization		—			2,952			—		—		2,952
Goodwill impairment charge		—			3,834			—		—		3,834
Intercompany (income) expenses		5,680			(5,680	)		—		—		—
Interest expense, net		9,267			(300	)		—		—		8,967
Total expenses		15,351			77,278			—		—		92,629
Operating income (loss)		(15,351	)		275			—		—		(15,076	)
Earnings in investments in subsidiaries		(157	)		—			—		157		—
Equity in loss of joint venture		—			(106	)		—		—		(106	)
Income (loss) before income taxes		(15,508	)		169			—		157		(15,182	)
Provision (benefit) for income taxes		(2,279	)		326			—		—		(1,953	)
Net income (loss)	$	(13,229	)	$	(157	)	$	—	$	157	$	(13,229	)

LifeCare Holdings, Inc.

Condensed Consolidating Statement of Operations

For the Nine Months Ended September 30, 2007

(in thousands)

	Parent			Guarantor Subsidiaries			Nonguarantor Subsidiaries		Eliminations			Consolidated Totals
Net patient service revenue	$	—		$	242,475		$	—	$	—		$	242,475
Salaries, wages and benefits		528			117,076			—		—			117,604
Supplies		—			24,951			—		—			24,951
Rent		—			15,691			—		—			15,691
Other operating expenses		641			62,645			—		—			63,286
Provision for doubtful accounts		—			4,287			—		—			4,287
Depreciation and amortization		—			8,685			—		—			8,685
Goodwill impairment charge		—			3,834			—		—			3,834
Intercompany (income) expenses		8,410			(8,410	)		—		—			—
Interest expense, net		26,953			(487	)		—		—			26,466
Total expenses		36,532			228,272			—		—			264,804
Operating income (loss)		(36,532	)		14,203			—		—			(22,329	)
Earnings in investments in subsidiaries		13,262			—			—		(13,262	)		—
Equity in loss of joint venture		—			(448	)		—		—			(448	)
Income (loss) before income taxes		(23,270	)		13,755			—		(13,262	)		(22,777	)
Provision (benefit) for income taxes		(3,145	)		493			—		—			(2,652	)
Net income (loss)	$	(20,125	)	$	13,262		$	—	$	(13,262	)	$	(20,125	)

17

LifeCare Holdings, Inc.

Condensed Consolidating Statement of Cash Flows

For the Nine Months Ended September 30, 2007

(in thousands)

	Parent			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminations			Consolidated Totals
Cash flows from operating activities:
Net income (loss)	$	(20,125	)	$	13,262		$	—		$	(13,262	)	$	(20,125	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		1,180			8,685			—			—			9,865
Provision for doubtful accounts		—			4,287			—			—			4,287
Impairment charges		—			3,834			—			—			3,834
Equity in loss of joint venture		—			448			—			—			448
Deferred income taxes		2,087			—			—			—			2,087
Equity compensation amortization		519			—			—			—			519
Changes in operating assets and liabilities:
Accounts receivable		—			(7,409	)		—			—			(7,409	)
Current income taxes		—			(2,169	)		—			—			(2,169	)
Prepaid expenses and other current assets		(2,285	)		1,337			(6	)		—			(954	)
Change in investments in subsidiary		(13,262	)		—			—			13,262			—
Other assets		(1,090	)		959			—			—			(131	)
Due to from related parties		38,325			(38,312	)		(13	)		—			—
Estimated third-party payor settlements		—			(7,884	)		—			—			(7,884	)
Accounts payable and accrued expenses		(2,968	)		4,704			1,586			—			3,322
Other liabilities		(36	)		1,545			—			—			1,509
Net cash provided by (used in) operating activities		2,345			(16,713	)		1,567			—			(12,801	)
Cash from investing activities:
Purchases of property and equipment		205			(25,424	)		(12,033	)		—			(37,252	)
Sale-leaseback proceeds		—			26,669			—			—			26,669
Net cash provided by (used in) investing activities		205			1,245			(12,033	)		—			(10,583	)
Cash flows from financing activities:
Deferred financing costs		—			(1,089	)		—			—			(1,089	)
Proceeds from lease financing obligation		—			—			10,466			—			10,466
Payments of notes payable and long-term debt		(2,550	)		—			—			—			(2,550	)
Payments on obligations under capital leases		—			(3,122	)		—			—			(3,122	)
Net cash provided by (used in) financing activities		(2,550	)		(4,211	)		10,466			—			3,705
Net decrease in cash and cash equivalents		—			(19,679	)		—			—			(19,679	)
Cash and cash equivalents, beginning of period		—			33,250			—			—			33,250
Cash and cash equivalents, end of period	$	—		$	13,571		$	—		$	—		$	13,571

18

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This discussion and analysis should be read in conjunction with our condensed consolidated financial statements and the accompanying notes.

Company Overview

We began operations in 1993 and have grown our business through developing and acquiring hospitals to become a leading operator of long-term acute care (“LTAC”) hospitals in the United States. As of September 30, 2008 we operated 20 hospitals located in 10 states, consisting of nine “hospital within a hospital” (“HIH”) facilities (29% of beds) and 11 freestanding facilities (71% of beds). Through these 20 long-term acute care hospitals, we operate a total of 1,079 licensed beds and employ approximately 3,200 people, the majority of whom are registered or licensed nurses and respiratory therapists.

We believe we have developed a reputation for excellence in providing treatment for patients with complex medical needs requiring extended treatment. Our patients have serious medical conditions such as respiratory failure, chronic pulmonary disease, nervous system disorders, infectious diseases and severe wounds. They generally require a high level of monitoring and specialized care, yet may not require the continued services of an intensive care unit. Due to their serious medical conditions, our patients are generally not clinically appropriate for admission to a skilled nursing facility or inpatient rehabilitation facility. By combining general acute care services with a focus on long-term treatment, we believe that our hospitals provide medically complex patients with better and more cost-effective outcomes.

Recent Trends and Events

Impact of Hurricane Katrina

At the time of Hurricane Katrina, we operated an 82-bed facility in New Orleans located in Memorial Medical Center. In the aftermath of the hurricane, an investigation was conducted by the Louisiana Attorney General’s office. The investigation culminated in a Grand Jury being convened in February of 2007 to determine if criminal charges should be filed against three

19

individuals, who were not our employees, but who were caring for patients in Memorial Medical Center after the hurricane. Two of the individuals were subsequently granted immunity and the Grand Jury declined to indict the third. Neither the Company nor its employees have been named in any illegal or criminal activities associated with Hurricane Katrina.

We are currently defending ourselves against a variety of Hurricane Katrina related lawsuits and matters under review by the Louisiana Patient Compensation Fund. We are vigorously defending ourselves in these lawsuits, however, we cannot predict the ultimate resolution of these matters. We maintained $15.0 million of general and professional liability insurance during this period, subject to a $1.0 million per claim retention. We believe that under our insurance policies, only one retention is applicable to the Hurricane Katrina matters since these matters all arose from a single event, process or condition. Our insurance carriers are currently paying all costs related to these claims, but have sent reservation of rights letters which challenge, among other things, the application of one retention to the Hurricane Katrina related matters. To the extent it is ultimately determined that a separate retention applies to each of these claims, we could experience significant losses related to these Hurricane Katrina matters which would negatively impact our financial position, liquidity and results of operations.

Hospital Openings and Closings

In April 2008, we opened a new 60-bed freestanding facility in Boise, Idaho, and added 10 beds to our Denver facility. During the first quarter of 2007, we terminated the lease at the Doctors Hospital campus in Shreveport, Louisiana. Eight beds were transferred to another location and the 11 beds remaining at this location were closed. Eight beds were added to our Denver, Colorado location during the same period. In June 2007, we opened a 62-bed freestanding hospital in San Antonio, Texas, which replaced a 34-bed HIH in San Antonio that was closed in the same month. In August 2007, 21 additional beds were added to our Denver location. In September 2007, we opened a 62-bed freestanding hospital in Milwaukee, Wisconsin, which replaced a 35-bed HIH in Milwaukee that was closed in the same month. Additionally, during September 2007 we added 10 intensive care unit level beds to our hospital located in Fort Worth, Texas.

The assets formerly located in our hospitals that were closed or relocated are being used at other locations or were disposed.

Regulatory Changes

Approximately 60.9% and 64.7% of our total net patient service revenue for the nine months ended September 30, 2008 and 2007, respectively, came from Medicare reimbursement. Our industry is subject to extensive government regulation, including regulation of the Medicare reimbursement process. Changes in these regulations can have a material impact on the way we operate our business and on our results of operations.

The 2008 Final Rule

On May 2, 2008, the Centers for Medicare & Medicaid Services (“CMS”) issued its annual regulatory update regarding Medicare reimbursement for LTAC hospitals that will be effective for all discharges on or after July 1, 2008 (the “2008 Final Rule”). The 2008 Final Rule included, among other things, (1) an increase in the standard federal rate to $39,114, which represents a 2.7% increase, and (2) an increase in the high-cost outlier threshold of $2,222 to $22,960. Additionally, CMS is changing the timetable for annual updates to a fiscal year schedule starting on October 1 instead of July 1, which will result in the 2009 rate year rates being in effect for 15 months beginning July 1, 2008. CMS has estimated that the proposed changes for the 2009 rate year, taken as a whole, will result in an increase of 2.5% in Medicare reimbursement to LTAC hospitals. Individual hospitals, however, will see varying effects of this rule depending on their Medicare patient population and their specific base rate changes due to geographical location.

CMS Changes to DRG Weighting for Fiscal 2009

On July 31, 2008, CMS issued its final regulations regarding the re-weighting of Medicare-Severity DRGs (“MS-LT-DRG”) that will become effective for discharges on or after October 1, 2008. CMS has indicated that these changes were made in a budget-neutral manner and that aggregate LTAC hospital payments will be unaffected by these changes. It is likely, however, that individual hospitals will see varying effects of this rule depending upon the acuity levels of their Medicare patient populations.

The Medicare, Medicaid and SCHIP Extension Act of 2007

On December 29, 2007, legislation known as the Medicare, Medicaid and SCHIP Extension Act of 2007 (the “MMSEA”) was signed into law and became effective for cost reporting periods beginning after December 29, 2007. This legislation provides for, among other things:

1) enhanced medical necessity reviews of LTAC hospital cases and a mandated study by the Secretary of Health and Human Services on the establishment of LTAC hospital certification criteria;

20

2) three-year moratoriums on the following:

a. the establishment of a LTAC hospital or satellite facility, subject to exceptions for facilities under development;

b. an increase in the number of beds at a LTAC hospital or satellite facility, subject to exceptions for states where there is only one LTAC hospital or upon request following the closure or decrease in the number of beds at a LTAC hospital within the state;

c. the application of the so-called “25 Percent Rule” to freestanding and grandfathered LTAC hospitals;

d. the very short-stay outlier payment reductions to LTAC hospitals initially implemented on May 11, 2007; and

e. the application of a one-time budget neutrality adjustment of payment rates to LTAC hospitals under the Long-Term Acute Care Prospective Payment System (“PPS”);

3) a three-year period during which certain types of LTAC hospitals that are co-located within another hospital may admit up to 50% of their patients from the host hospitals and still be paid according to the LTAC hospital PPS;

4) a three-year period during which certain types of LTAC hospitals that are co-located with an urban single hospital or a hospital that generates more than 25% of the Medicare discharges in a metropolitan statistical area (“MSA Dominant hospital”) may admit up to 75% of their patients from such urban single hospital or MSA Dominant hospital and still be paid according to the LTAC prospective payment system; and

5) the elimination of the July 1, 2007 market basket increase in the standard federal payment rate of 0.71%, effective for discharges occurring on or after April 1, 2008.

Additionally, the MMSEA expanded the definition of a LTAC hospital. Historically, for a hospital to be certified as a LTAC hospital, the primary requirement was the average length of stay for Medicare patients, measured annually at the end of a cost report period, be in excess of 25 days. The MMSEA modified this definition to include, among other items, that the LTAC hospital has a patient review process that screens patients prior to admission for appropriateness of admission, validates within 48 hours of admission that patients meet admission criteria, regularly evaluates patients during their stay and assesses available discharge options when patients fail to continue to meet stay criteria.

We believe that the additional certification criteria will not impact the certification status of our LTAC hospitals.

CMS Changes to DRG Weighting for Fiscal 2008

On August 1, 2007, CMS issued final inpatient prospective payment system regulations for fiscal year 2008. These regulations establish a new Medicare severity-based patient classification system for fiscal year 2008, called MS-LT-DRG for LTAC hospitals. The MS-LT-DRG system creates additional severity-adjusted categories for most diagnoses, resulting in an expansion of the number of DRGs from 538 to 745. CMS states that MS-LT-DRG weights were developed in a budget neutral manner and as such, the estimated aggregate payments under LTAC PPS would be unaffected by the annual recalibration of MS-LT-DRG payment weights. CMS has provided for a two year phase-in period to mitigate the transition in payments for short-term acute and LTAC PPS providers. In fiscal 2008, provider reimbursements are based 50% on new MS-LT-DRGs and 50% on existing DRGs. For fiscal 2009, 100% will be based on new MS-LT-DRGs.

CMS also stated that future annual updates to the DRG classifications and relative weights will be made in a budget neutral manner, effective October 1, 2007. As such, it is expected that the estimated aggregate industry LTAC hospital PPS payments would be unaffected by the annual recalibration of DRG payment weights.

The 2007 Final Rule

On May 1, 2007, CMS issued its annual regulatory update regarding Medicare reimbursement for LTAC hospitals (the “2007 Final Rule”) that was effective for all discharges on or after July 1, 2007. This rule was amended on June 29, 2007, by revising the high cost outlier threshold. CMS estimated that the impact of the 2007 Final Rule was an overall net decrease in payments to all Medicare certified LTAC hospitals of approximately 1.2%. The 2007 final rule included, among other things, (1) an increase to the standard federal payment rate of 0.71% (subsequently eliminated effective April 1, 2008, as provided for in the SCHIP Extension Act as previously discussed); (2) revisions to payment methodologies impacting short-stay outliers, which reduce payments by 0.9% (also subsequently modified by the SCHIP Extension Act via three-year moratorium on this new provision); (3) adjustments to the wage index component of the federal payment resulting in projected reductions in payment of 0.5%; (4) an increase in the high cost outlier threshold per discharge to $20,738, resulting in projected reimbursement reductions of 0.4%; and (5) an extension of the policy known as the “25 Percent Rule” to all LTAC hospitals, with a three-year phase in, which CMS projects will not result in payment reductions for the first year of implementation (also subsequently modified by the SCHIP Extension Act via a three-year moratorium on this provision).

21

A significant policy change contained in the 2007 Final Rule was the application of the so-called “25 Percent Rule” to all LTAC hospitals. The result of this policy change was that all LTAC hospitals were to be paid the LTAC PPS rates for admissions from a single referral source up to 25% of aggregate Medicare admissions. Admissions in excess of the 25% threshold were to be paid at a lesser amount based upon short-term acute care hospital rates. Patients admitted who had previously reached a high cost outlier status in the referring short-term hospital were not counted when computing compliance with this limitation.

Regulatory Matters

On June 12, 2006 we entered into a Settlement Agreement and a Certification of Compliance Agreement (“CCA”) with the Office of Inspector General of the Department of Health and Human Services (“OIG”) that settled certain cost report matters for the years 1997 to 2001. The CCA is effective for three years from the date of the CCA, and requires, among other things, that we continue to maintain our corporate compliance program, report certain events if they occur to the OIG and that we file an annual report with the OIG regarding certain specified items, including our on-going corporate compliance audit findings in areas such as cost reports, physician contracting and charge master reviews.

Sources of Revenue

We are reimbursed for our services provided to patients by a number of sources, including the federal Medicare program and commercial payors. Payment arrangements include prospectively determined rates per discharge, reimbursed costs, discounted charges and per diem rates. Our net patient service revenue consists of the amounts that we estimate to be reimbursable from each of the applicable non-governmental payors and the Medicare and Medicaid programs. We account for the differences between the estimated reimbursement rates and our standard billing rates as contractual adjustments, which are deducted from gross revenues to arrive at net revenues. We record accounts receivable resulting from such payment arrangements net of contractual allowances. Net patient service revenues generated directly from the Medicare program approximated 60.9% and 64.7% of total net patient service revenue for the nine months ended September 30, 2008 and 2007, respectively. Net patient service revenues generated from non-Medicare payors were primarily from commercial payors.

Laws and regulations governing provider reimbursement pursuant to the Medicare program are complex and subject to interpretation. The Medicare reimbursement amounts reported in our financial statements are based upon estimates and, as such, are subject to adjustment until such time as our billings and cost reports are filed and settled with the appropriate regulatory authorities. Federal regulations require that providers participating in the Medicare program submit annual cost reports associated with services provided to program beneficiaries. In addition, payments under LTACH PPS are subject to review by the regulatory authorities. These reviews primarily focus on the accuracy of the DRG assigned to each discharged patient and normally occur after the completion of the billing process.

The annual cost reports are also subject to review and adjustment by CMS through its fiscal intermediaries. These reviews may not occur until several years after a provider files its cost reports and often results in adjustments to amounts reported by providers in their cost reports as a result of the complexity of the regulations and the inherent judgment that is required in the application of certain provisions of provider reimbursement regulations. Since these reviews of filed cost reports occur periodically, there is a possibility that recorded estimated Medicare reimbursement reflected in our consolidated financial statements and previously filed cost reports may change by a material amount in future periods. We recognize in our consolidated financial statements the impact of adjustments, if any, to estimated Medicare reimbursement when the amounts can be reasonably determined.

In 2007, one of our hospitals, with multiple campus locations, failed to achieve the twenty-five day length of stay requirement for the twelve months ended December 31, 2007. The LTAC hospital regulations provide that a hospital may correct this type of deficiency in the subsequent cost report period following the period in which the twenty-five day length of stay requirement was not achieved. The fiscal intermediary for this hospital reviewed the hospital’s discharge information for the five months ending May 31, 2008 for compliance with the twenty-five day length of stay requirement. Based upon this review, the fiscal intermediary determined that the hospital met the twenty-five day length of stay requirement and issued their recommendation to CMS that the hospital continue to be certified as an LTAC hospital. The hospital is currently eligible and will continue to be eligible to receive Medicare payments pursuant to LTAC hospital regulations for discharges on or after January 1, 2009. We believe that this hospital, and our remaining hospitals, are currently in compliance with the Medicare regulations regarding LTAC hospitals and will maintain compliance under these regulations.

22

Total Expenses

Total expenses consists of salaries, wages and benefits, supplies (which includes expenses related to drug and medical supplies), rent, other operating expenses, provision for doubtful accounts, depreciation and amortization and interest expense. Other operating expenses include expenses such as contract labor, legal and accounting fees, insurance and contracted services purchased from host hospitals.

Other Operating Metrics

We use certain operating metrics in the management of our facility operations. These include:

Licensed beds. Licensed beds represent beds for which a facility has been granted approval to operate from the applicable state licensing agency. These licensed beds are used in the determination of average licensed beds and occupancy rates.

Average licensed beds. We compute average licensed beds by computing a weighted average based upon the number of licensed beds in place for each month within the reporting period.

Admissions. Admissions are the total number of patients admitted to our facilities during the reporting period.

Patient days. Patient days are the cumulative number of days that licensed beds are occupied in our facilities for the entire reporting period. We also refer to patient days as our census.

Average length of stay (days). We compute average length of stay in days by dividing patient days for discharged patients by discharges.

Occupancy rates. We compute our occupancy rate by determining the percentage of average licensed beds that are occupied for a 24-hour period during a reporting period. The occupancy rate provides a measure of the utilization of inpatient rooms.

Net patient service revenue per patient day. This measure is determined by dividing our total net patient service revenue by the number of patient days in a reporting period. We use this metric to provide a measure of the net patient service revenue generated for each patient day.

Critical Accounting Matters

This discussion and analysis of our financial condition and results of operation is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of those financial statements requires the use of estimates and judgments that affect the reported amounts and related disclosures. We rely on historical experience and other assumptions that we believe are reasonable at the time in forming the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual amounts may differ from these estimates.

We believe that the following critical accounting policies, more fully described in our annual financial statements as of December 31, 2007 as filed in the Form 10-K, affect the more significant judgments and estimates used in the preparation of our consolidated financial statements.

• Revenue recognition

• Accounts receivable and allowance for doubtful accounts

• Insurance risks

• Impairment of long-lived assets

• Accounting for income taxes

• Accounting for stock-based compensation

Goodwill

We review our goodwill annually, or more frequently if circumstances warrant a more timely review, to determine if there has been an impairment. Per the guidance of Financial Accounting Standards Board Emerging Issues Task Force (“EITF”) Topic No. D-101 Clarification of Reporting Unit Guidance in Paragraph 30 of FASB Statement No. 142, (“EITF Topic No. D-101”), we review goodwill based upon one reporting unit, as the Company is managed as one operating segment in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 131, Disclosures about Segments of an Enterprise and Related Information, (“SFAS 131”). In calculating the fair value of the reporting unit, we use various assumptions including projected cash flows and discount rates. If projected future cash flows decline from the current amounts projected by management, additional impairments may be recorded.

23

We are assessing the financial impact that the CMS regulations issued on May 2, 2008, as discussed previously, will have on our operations. It is possible that the impact may result in recording impairment charges in future periods as it relates to the carrying value of goodwill and identifiable intangible assets.

Results of Operations

The following table sets forth operations results for each of the periods presented (in thousands):

	Three Months Ended September 30						Nine Months Ended September 30
	2008			2007			2008			2007
Net patient service revenue	$	82,394		$	77,553		$	257,786		$	242,475
Salaries, wages and benefits		40,520			40,389			123,411			117,604
Supplies		8,353			8,191			26,209			24,951
Rent		6,331			5,712			19,060			15,691
Other operating expenses		19,902			21,180			61,475			63,286
Provision for doubtful accounts		151			1,404			2,600			4,287
Depreciation and amortization		3,018			2,952			8,605			8,685
Goodwill impairment charges		—			3,834			—			3,834
Interest expense, net		9,209			8,967			28,135			26,466
Total expenses		87,484			92,629			269,495			264,804
Operating loss		(5,090	)		(15,076	)		(11,709	)		(22,329	)
Equity in loss of joint venture		—			(106	)		—			(448	)
Loss before income taxes		(5,090	)		(15,182	)		(11,709	)		(22,777	)
Provision (benefit) for income taxes		835			(1,953	)		1,259			(2,652	)
Net loss	$	(5,925	)	$	(13,229	)	$	(12,968	)	$	(20,125	)

Operating Statistics

The following table sets forth operating statistics for each of the periods presented.

	Three Months Ended September 30						Nine Months Ended September 30
	2008			2007			2008			2007
Number of hospitals within hospitals (end of period)		9			9			9			9
Number of freestanding hospitals (end of period)		11			10			11			10
Number of total hospitals (end of period)		20			19			20			19
Licensed beds (end of period)		1,079			1,008			1,079			1,008
Average licensed beds (1)		1,079			976			1,056			944
Admissions		1,974			1,972			6,315			5,868
Patient days		55,329			55,616			176,927			172,042
Occupancy rate		55.7	%		61.9	%		61.1	%		66.8	%
Percent net patient service revenue from Medicare		60.4	%		60.8	%		60.9	%		64.7	%
Percent net patient service revenue from commercial payors and Medicaid (2)		39.6	%		39.2	%		39.1	%		35.3	%
Net patient service revenue per patient day	$	1,489		$	1,394		$	1,457		$	1,409

(1) The average licensed beds are only calculated on the beds at locations that were open for operations during the applicable periods.

(2) The percentage of net patient service revenue from Medicaid is less than one percent for each of the periods presented.

24

Three Months Ended September 30, 2008 Compared to Three Months Ended September 30, 2007

Net Revenues

Our net patient service revenue of $82.4 million for the three months ended September 30, 2008, increased by $4.8 million, or 6.2%, as compared to the same period in 2007. Patient days and admissions during the current year period were consistent with the prior year period. The increase in net patient service revenue was comprised of a $5.2 million benefit as the result of increased revenue per patient day offset by an unfavorable variance of $0.4 million from a decrease in patient days.

During the three months ended September 30, 2008 our net patient service revenue per patient day was $1,489, as compared to $1,394 for the 2007 period. The increase in net patient service revenue on a per patient day basis during the 2008 period was primarily the result of annual inflationary increases in our standard charge rates and certain of our contracts with commercial payors, an increase in the percentage of our revenues generated from commercial payors, and the marginal increases contained in the annual regulatory updates implemented by Medicare in the 2008 Final Rule.

Total Expenses

Total expenses decreased by $5.1 million to $87.5 million for the three months ended September 30, 2008 as compared to $92.6 million for the comparable period in 2007. The 2007 period included $2.5 million for compensation and benefits accrued in connection with the departure of the CEO during 2007 and $3.8 million related to goodwill impairment charges.

Excluding these items, total expenses increased by $1.2 million during the 2008 period as compared to the 2007 period. Other operating expenses decreased by $1.3 million in the 2008 period due mainly to a decrease in insurance expense as the result of favorable premium trends and experience trending. The provision for doubtful accounts decreased by $1.3 million as the result of increased collections on aged accounts previously reserved for and favorable accounts receivable aging trends. Offsetting these decreases were increases in salaries, wages and benefits of $2.6 million and an increase in rent expense of $0.6 million. The increase in salaries, wages and benefits was due mainly to inflationary increases and the expansion of bed capacity as discussed previously. The increase in rent expense was also due to the expansion of bed capacity.

Income Tax Expense

For the three months ended September 30, 2008, income tax expense recorded represents the estimated income tax liability for certain state income taxes and revised estimates to the beginning of the year valuation allowance based on the final filing of amended tax returns for 2003 to 2006. We expect that no benefit or expense will be realized during 2008 for current year federal income taxes based on recent taxable loss trends and a projected taxable loss for the remainder of 2008. We anticipate that federal net operating losses generated during 2008 will be offset by an increase in the valuation allowance against net deferred tax assets.

Nine Months Ended September 30, 2008 Compared to Nine Months Ended September 30, 2007

Net Revenues

Our net patient service revenue increased by $15.3 million, or 6.3%, for the nine months ended September 30, 2008, to $257.8 million from $242.5 million for the comparable period in 2007. Patient days and admissions increased 2.8% and 7.6%, respectively, for the nine months ended September 30, 2008 compared to the same period in 2007.

This increase in net patient service revenue was comprised of a $6.9 million favorable benefit from an increase in patient days and a favorable $8.4 million variance as the result of increased revenue per patient day. This increase in patient days and admissions was partially attributable to the expansion of our operations, as discussed previously.

Our net patient service revenue per patient day during the nine months ended September 30, 2008 and 2007, was $1,457 and $1,409, respectively. The increase in net patient service revenue on a per patient day basis during the 2008 period was primarily the result of annual inflationary increases in our standard charge rates and certain of our contracts with commercial payors, an increase in the percentage of our revenues generated from commercial payors, and the marginal increases contained in the annual regulatory updates implemented by Medicare in the 2008 Final Rule.

Total Expenses

Total expenses increased by $4.7 million to $269.5 million for the nine months ended September 30, 2008 as compared to $264.8 million for the comparable period in 2007. Included in the expenses for the nine month period ending September 30, 2007, is a $3.8 million impairment charge related to goodwill and $2.5 million attributable to compensation and benefits accrued in connection with the departure of the CEO during the three months ended September 30, 2007.

25

Excluding the impairment charge and the compensation and benefits accrual for 2007, expenses increased by $11.0 million from the same period in the prior year. Rent expenses increased by $3.4 million during the 2008 period in connection with the increases in bed capacity as discussed previously. Net interest expense increased by $1.7 million during the 2008 period due mainly to increased interest margins on our senior secured credit facility and borrowings under our revolving credit facility as discussed further in the Liquidity and Capital Resources section contained herein. The remaining $5.9 million increase in expenses was primarily attributable to an increase in salaries, wages and benefits due to inflationary increases and the increases in bed capacity as previously discussed.

Income Tax Expense

For the nine months ended September 30, 2008, income tax expense recorded represents the estimated income tax liability for certain state income taxes and revised estimates to the beginning of the year valuation allowance based on the final filing of amended tax returns for 2003 to 2006. We expect that no benefit or expense will be realized during 2008 for current year federal income taxes based on recent taxable loss trends and a projected taxable loss for the remainder of 2008. We anticipate that federal net operating losses generated during 2008 will be offset by an increase in the valuation allowance against net deferred tax assets.

Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, expected cash flows generated by operations, and availability of borrowings under a revolving credit facility. Availability of borrowings under our Revolving Credit Facility are generally dependent upon our ability to meet the maximum leverage ratio test included in the senior secured credit facility. Our primary liquidity requirements are for debt service on our senior secured credit facilities and the notes, capital expenditures and working capital.

At September 30, 2008, our debt structure consisted of $147.0 million aggregate principal amount of senior subordinated notes, a senior secured credit facility, consisting of (i) a $247.4 million term loan facility which matures on August 11, 2012, and (ii) a $60.0 million revolving credit facility, subject to availability, of which $10.0 million is outstanding, including sub-facilities for letters of credit and swingline loans, which matures on August 11, 2011. We also have capital lease obligations of $3.4 million with varying maturities. The full amount available under the term loan facility was used in connection with the Transactions, as discussed in the Form 10-K we filed on March 28, 2008 with the Securities and Exchange Commission.

The senior secured credit facility requires us to comply on a quarterly basis with certain financial covenants, including an interest coverage ratio test and a maximum leverage ratio test. These financial covenants become more restrictive on a periodic basis throughout the remaining term of the senior secured credit facility beginning with the fiscal period ended December 31, 2008. In addition, the senior secured credit facility includes various negative covenants, including limitations on indebtedness, liens, investments, permitted businesses and transaction and other matters, as well as certain customary representations and warranties, affirmative covenants and events of default including payment defaults, breach of representations and warranties, covenant defaults, cross defaults to certain indebtedness, certain events of bankruptcy, certain events under ERISA, material judgments , actual or asserted failure of any guaranty or security document supporting the senior secured credit facility to be in full force and effect, change of control, and certain subjective provisions. We believe we are currently in compliance with the covenants of our senior secured credit facility as amended.

The interest rates per annum applicable to loans, other than swingline loans, under our senior secured credit facility are, at our option, equal to either an alternate base rate or an adjusted LIBOR rate for a one-, two-, three- or six-month interest period, or a nine- or twelve-month period if available, in each case, plus an applicable margin. The applicable margins on the loans as amended are currently (1) 3.25% for alternate base rate revolving loans, (2) 4.25% for adjusted LIBOR revolving loans, (3) 3.25% for alternate base rate term loans and (4) 4.25% for adjusted LIBOR term loans. These margins are subject to reduction based upon the ratio of our total indebtedness to our consolidated adjusted EBITDA (as defined in the credit agreement governing our senior secured credit facility and amendment number one to the credit agreement). At September 30, 2008, the interest rate applicable to the $247.4 million under our term loan facility, and the $10.0 million outstanding balance of the revolving credit facility was 7.05%.

We may not be able to continue to satisfy the covenant requirements in subsequent periods. If we are unable to maintain compliance with the covenants contained in our senior secured credit facility, an event of default would occur. During the continuation of an event of default, the lenders under the senior secured credit facility are entitled to take various actions, including accelerating amounts due under the senior secured credit facility, terminating our access to our revolving credit facility and all other actions generally available to a secured creditor. An uncured event of default would have a material adverse effect on our financial position, results of operations and cash flow. In the event a financial covenant is not met, our senior secured credit facility provides for certain limited cure rights which provide us the ability to issue permitted cure securities in exchange for cash or otherwise receive cash that would be contributed to our capital in an amount that is

26

necessary to satisfy the financial covenant required on a pro forma basis. The cure right amount, if exercised, continues to be considered a component of consolidated EBITDA, as defined in the senior secured credit agreement, on a trailing 4 quarter basis. A cure right was exercised for the fiscal quarter ended September 30, 2007 in the amount of $6.0 million. This cure amount was a component of consolidated EBITDA for financial covenant purposes through the fiscal period ended June 30, 2008. This particular cure amount, however, will not be included in the current or subsequent fiscal periods for financial covenant test purposes.

We believe that our cash on hand, expected cash flows from operations, and potential availability of borrowings under the revolving portion of our senior secured credit facilities will be sufficient to finance our operations, and meet our scheduled debt service requirements for at least the next twelve months.

On September 1, 2006, a newly formed subsidiary of the Company entered into a Master Lease Agreement (“Lease”) with Health Care REIT, Inc. In connection with this Lease, Health Care REIT, Inc. agreed to make available up to $250 million for investments in hospital facilities, subject to approval of the Landlord and certain terms and conditions. Our Boise, Idaho facility was the first facility to be developed under this Lease. This facility was completed in March 2008 with construction cost of approximately $19.6 million. Through September 30, 2008, Health Care REIT, Inc. had made payments to us of approximately $18.9 million as reimbursement for these capital expenditures. This facility opened in April 2008. This particular facility under this Lease is accounted for as a lease financing obligation whereby the asset remains capitalized on our balance sheet. See note 8 in our condensed consolidated financial statements for additional discussion regarding this Lease.

We actively seek to identify and evaluate potential acquisition candidates and, from time to time, we review potential acquisitions of businesses. Any acquisitions may require us to issue additional equity or incur additional indebtedness, subject to the limitations contained in our senior secured credit facility.

Capital Expenditures

We anticipate that we will incur capital expenditures of approximately $2.3 million during the remainder of 2008 based on our current plans, which includes remaining equipment needs at our Boise, Idaho facility and our ongoing capital maintenance expenditure requirements at our existing facilities. We may enter into lease arrangements to finance a portion of these equipment expenditures.

Historical Cash Flow

The following table summarizes the net cash provided by (used in) the statement of cash flows (in thousands):

	Nine Months Ended September 30
	2008			2007
Operating activities	$	831		$	(12,801	)
Investing activities		(8,008	)		(10,583	)
Financing activities		11,614			3,705

For the nine months ended September 30, 2008, cash provided by operating activities was $0.8 million as compared to a use of cash of $12.8 million for the comparable period in 2007. For the nine-months ended September 30, 2008, we had a net loss of $13.0 million as compared to a net loss of $20.1 million for the same period in 2007. The net loss for the 2007 period included a $3.8 million impairment charge. Excluding the impairment charge, the loss for the 2008 period decreased by $3.3 million from a loss of $16.3 million to a loss of $13.0 million in the 2008 period.

Accounts receivable increased by $2.7 million for the nine months ended September 30, 2008, as compared to an increase of $7.4 million for same period during 2007. Days of net patient service revenue in accounts receivable at September 30, 2008 had decreased to 75.1, as compared to 77.6 at December 31, 2007. Additionally, estimated third-party payor settlements increased by $3.2 million during the nine-months ended September 30, 2008 as compared to an increase of $7.9 million during the 2007 period. An increase in accounts payable and accrued expenses provided net cash of $4.6 million for the nine months ended September 30, 2008 as compared to providing net cash of $3.3 million in the comparable period in 2007.

Cash used in investing activities was $8.0 million and $10.6 million for the nine months ended September 30, 2008 and 2007, respectively. Cash used during the 2008 period was principally for the construction of our hospital in Boise, Idaho. This was offset by $3.7 million received in the 2008 period pursuant to our lease agreement with Healthcare REIT, Inc. attributable to our Milwaukee, Wisconsin facility. During the nine months ended September 30, 2007, we received $26.7 million of proceeds related to the lease agreement entered into with Health Care REIT, Inc. associated with our San Antonio, Texas and Milwaukee, Wisconsin facilities.

27

Cash provided by financing activities for the nine months ended September 30, 2008 was $11.6 million as compared to cash provided of $3.7 million for the same period in 2007. During the nine months ended September 30, 2008, we borrowed $10.0 million from our revolving line of credit. During the 2008 and 2007 periods, proceeds of $3.8 million and $10.5 million were received from Health Care REIT, Inc. for capital expenditures associated with our development project in Boise, Idaho.

Seasonality

Our business experiences seasonality resulting in variation in census levels, with the highest census historically occurring in the first quarter of the year and the lowest census occurring in the third quarter of the year.

Inflation

We derive a substantial portion of our revenue from the Medicare program. LTAC hospital PPS payments are subject to fixed payments that generally are adjusted annually for inflation. However, there can be no assurance that these adjustments, if received, will reflect the actual increase in our costs for providing healthcare services.

Labor and supply expenses make up a substantial portion of our operating expense structure. The expenses can be subject to increase in periods of rising inflation.

Forward Looking Statements

This quarterly report contains forward-looking statements regarding, among other things, our financial condition, results of operations, plans, objectives, future performance and business. All statements contained in this document other than historical information are forward-looking statements. Forward-looking statements include, but are not limited to, statements that represent our beliefs concerning future operations, strategies, financial results or other developments, and contain words and phrases such as “may,” “expects,” “believes,” “anticipates,” “estimates,” “should,” or similar expressions. Because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control or are subject to change, actual results could be materially different. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Important factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to:

• changes in government reimbursement for our services may have an adverse effect on our future revenues and profitability including, for example, the changes described under “Regulatory Changes”;

• the failure to maintain compliance with our financial covenants could be costly or have a material adverse effect on us;

• the amount of outstanding indebtedness and the restrictive covenants in the agreements governing our indebtedness may limit our operating and financial flexibility;

• the condition of the financial markets, including volatility and deterioration in the capital and credit markets, could have a material adverse effect on the availability and terms of financing sources;

• a government investigation or assertion that we have violated applicable regulations may result in increased costs or sanctions that reduce our revenues and profitability;

• private third-party payors for our services may undertake future cost containment initiatives that limit our future revenues and profitability;

• actions that may be brought by individuals on the government’s behalf under the False Claims Act’s qui tam or whistleblower provisions may expose us to unforeseen liabilities;

• the failure of our long-term acute care hospitals to maintain their qualification could cause our revenues and profitability to decline;

• the failure of our “satellite” facilities to qualify for provider-based status with the applicable “main” facilities may adversely affect our results of operations;

• development of new facilities may prove difficult or unsuccessful, use significant resources or expose us to unforeseen liabilities;

• an increase in uninsured and underinsured patients in our hospitals or the deterioration in the collectibility of the accounts of such patients could harm our results of operations;

28

• the failure to maintain established relationships with the physicians in our markets could reduce our revenues and profitability;

• shortages in qualified nurses or therapists could increase our operating costs significantly;

• competition may limit our ability to grow and result in a decrease in our revenues and profitability;

• the loss of key members of our management team could significantly disrupt our operations;

• the geographic concentration of our facilities in Texas make us sensitive to economic, regulatory, environmental and other developments in this state;

• adverse changes in individual markets could significantly affect operating results;

• the effect of legal actions or other claims associated with the circumstances arising from Hurricane Katrina could subject us to substantial liabilities;

• the effect of legal actions asserted against us or lack of adequate available insurance could subject us to substantial uninsured liabilities;

• ability to ensure and maintain an effective system of internal controls over financial reporting; and,

• the failure to comply with the provisions of any of our master lease agreements could materially adversely affect our financial position, results of operations and liquidity.

Consequently, such forward-looking statements should be regarded solely as our current plans, estimates and beliefs. We do not intend, and do not undertake, any obligation to update any forward-looking statements to reflect future events or circumstances after the date of this report.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

At September 30, 2008, we had $247.4 million in senior term loans outstanding, $10.0 million outstanding under our revolving credit facility and borrowing availability of $50.0 million under our revolving credit facility, each bearing interest at variable rates. Each 0.125% point change in interest rates would result in a $0.4 million annual change in interest expense on our term loans and revolving credit facility loans, assuming that our revolving credit facility is fully drawn. Pursuant to our senior term loan credit agreement we were required to enter into an interest rate swap agreement that would provide protection against fluctuations in interest rates on a notional amount of $12.0 million. On November 9, 2005, we entered into such an agreement for a three year period. This agreement caps the LIBOR rate used to compute interest on the notional amount of our senior term loan at six percent per annum. In the future, we may enter into additional interest rate swaps, involving exchange of floating for fixed rate interest payments, to reduce interest rate volatility.

ITEM 4: CONTROLS AND PROCEDURES

We carried out an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered in this report. The disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within required time periods, and include controls and disclosures designed to ensure that this information is accumulated and communicated to the company’s management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. Based on this evaluation, our principal executive officer and principal financial officer have concluded that as of September 30, 2008 our disclosure controls and procedures were effective to provide reasonable assurance that information required to be included in our periodic SEC reports is recorded accurately, processed, summarized and reported within the time periods specified in the relevant SEC rules and forms.

In addition, we reviewed our internal controls, and there have been no changes in our internal controls over financial reporting identified in connection with an evaluation that occurred during the quarter ended September 30, 2008 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II: OTHER INFORMATION

ITEM 1: LEGAL PROCEEDINGS

We are a party to various legal actions that arise in the ordinary course of business, as well as other litigation described elsewhere in this report. These actions are primarily related to malpractice claims covered under insurance policies; however, there may be some legal actions which are not insured. We are unable to predict the ultimate outcome of pending litigation and regulatory and other government investigations, nor can there be any assurance that the resolution of any litigation or investigation, either individually or in the aggregate, would not have a material adverse effect on our financial position, results of operations or liquidity.

29

Item 1A. Risk Factors

The risk factors included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2007, are supplemented as follows:

Adverse changes in general economic and business conditions could adversely affect the Company. The condition of the financial markets, including volatility and deterioration in the capital and credit markets, could have a material adverse effect on the availability and terms of financing sources.

ITEM 6: EXHIBITS

The exhibits to this report are listed in the Exhibit Index appearing on page 31 hereof.

30

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

LifeCare Holdings, Inc.
By:	/s/ G. Wayne McAlister
	G. Wayne McAlister
	Chief Executive Officer
By:	/s/ Chris A. Walker
	Chris A. Walker
	Chief Financial Officer

Dated: November 14, 2008

31

EXHIBIT INDEX

Exhibit	Description
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32